Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study (Q39394695)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study |
scientific article |
Statements
1 reference
Lopinavir/ritonavir combined with raltegravir or tenofovir/emtricitabine in antiretroviral-naive subjects: 96-week results of the PROGRESS study (English)
1 reference
Joseph Gathe
1 reference
Jacques Reynes
1 reference
Roger Trinh
1 reference
Federico Pulido
1 reference
Ruth Soto-Malave
1 reference
Roula Qaqish
1 reference
Min Tian
1 reference
Linda Fredrick
1 reference
Thomas Podsadecki
1 reference
Michael Norton
1 reference
Angela Nilius
1 reference
3 August 2012
1 reference
1 reference
Identifiers
1 reference